Newsroom

Sorted by: Latest

-

Textron Aviation inauguró un nuevo centro de servicios en Melbourne, en el aeropuerto de Essendon Fields, ampliando así el soporte a clientes de Cessna, Beechcraft y Hawker en la región de Asia-Pacífico

WICHITA, Kansas--(BUSINESS WIRE)--Textron Aviation Inc., una empresa de Textron Inc. (NYSE: TXT), anunció hoy que su nuevo centro de servicios en el aeropuerto de Essendon Fields de Melbourne ya está abierto para los clientes. Esto amplía el soporte directo de fábrica para clientes de Cessna, Beechcraft y Hawker en Australia y toda la región de Asia-Pacífico. Este centro, diseñado para fines específicos, refuerza la red global de servicios de Textron Aviation y refleja el compromiso a largo pla...
-

Power Integrations Reports First-Quarter Financial Results

SAN JOSE, Calif.--(BUSINESS WIRE)--Power Integrations announced financial results for the first quarter of 2026....
-

Verastem Oncology Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today reported financial results for the first quarter ended March 31, 2026, and highlighted recent business progress. “As we mark the one-year anniversary of the FDA-approval of AVMAPKI FAKZYNJA CO-PACK for KRAS-mutated recurrent low-grade serous ovarian cancer, I am incredibly proud of the progress we have made to delive...
-

The Trade Desk Reports First Quarter 2026 Financial Results

LOS ANGELES--(BUSINESS WIRE)--The Trade Desk, Inc. (“The Trade Desk,” the “Company” or “we”) (NASDAQ: TTD), a provider of a global technology platform for buyers of advertising, today announced financial results for its first quarter ended March 31, 2026. “Q1 was another strong quarter for The Trade Desk, with revenue growing to $689 million, representing 12% year-over-year growth,” said Jeff Green, CEO and Co-Founder of The Trade Desk. “We’re encouraged by the impact of the strategic upgrades...
-

BILL Reports Third Quarter Fiscal Year 2026 Financial Results and Announces $1.0 Billion Share Repurchase Authorization

SAN JOSE, Calif.--(BUSINESS WIRE)--BILL (NYSE: BILL), the financial operations platform trusted by nearly half a million businesses to manage, move, and maximize their money, today announced financial results for the third fiscal quarter ended March 31, 2026. “BILL’s mission-critical financial operations platform creates significant value for businesses and is resonating in the market,” said René Lacerte, BILL CEO and Founder. “The acceleration of AI presents an extraordinary opportunity for BI...
-

Consensus Cloud Solutions, Inc. Reports First Quarter 2026 Results; Reaffirms Full Year 2026 and Releases Q2 2026 Guidance

LOS ANGELES--(BUSINESS WIRE)--Consensus Cloud Solutions, Inc. (NASDAQ: CCSI) today reported financial results for the first quarter of 2026. “I am pleased that our Q1 achievements continued the momentum from 2025. We continued to see strength in our corporate channel, which exceeded 8% revenue growth in the quarter and had the highest year over year revenue growth since Q4 2022. We also saw improvement in the SoHo channel ahead of our expectations. We were able to repurchase approximately 600,0...
-

AN2 Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company advancing novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, Co-Founder, Chairman, President and CEO will participate in a fireside chat at the 2026 Stifel Virtual Targeted Oncology Forum on May 19, 2026 at 4:00 PM ET, and members of management will be available for 1x1 meetings. A webcast can be accessed on the Investors section of t...
-

Perdoceo Education Corporation Announces First Quarter 2026 Results

SCHAUMBURG, Ill.--(BUSINESS WIRE)--PERDOCEO EDUCATION CORPORATION ANNOUNCES FIRST QUARTER 2026 RESULTS....
-

Rocket Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Progress

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, commercial-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today reported financial and recent operational results for the first quarter ended March 31, 2026. “During the first quarter, we continued advancing our cardiovascular gene therapy portfolio, including reinitiating dosing in the initial three-patient cohort of our p...
-

Aptar Pharma Announces Progress on Multi-Year U.S. FDA-Funded Research Contract

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Pharma's announces progress on research contract with U.S. FDA on advancing scientific understanding related to transition of MDIs toward NGPs....